A 1-year study to compare the efficacy and safety of once-daily travoprost 0.004%/timolol 0.5% to once-daily latanoprost 0.005%/timolol 0.5% in patients with open-angle glaucoma or ocular hypertension

Abstract

European Journal of Ophthalmology172183-190EJOO

    Similar works

    Full text

    thumbnail-image

    Available Versions